Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A0KFRJ1
Fri, 03.02.2023       bioXXmed AG
DE000A0KFRJ1

Centaur Pharmaceuticals Pvt Ltd increases sales with Woxheal® - ongoing open label marketing study in numerous Indian centres Darmstadt, 2nd February, 2023 - The Management Board of bioXXmed AG and Centaur Pharmaceuticals created a new basis for future cooperation between the two companies during a visit of Centaur in Mumbai. Centaur has increase [ … ]
Technical analysis
To the publication
Fri, 03.02.2023       bioXXmed AG
DE000A0KFRJ1

Centaur Pharmaceuticals Pvt Ltd increases sales with Woxheal® - ongoing open label marketing study in numerous Indian centres Darmstadt, 2nd February, 2023 - The Management Board of bioXXmed AG and Centaur Pharmaceuticals created a new basis for future cooperation between the two companies during a visit of Centaur in Mumbai. Centaur has increase [ … ]
Technical analysis
To the publication
Thu, 30.09.2021       CytoTools AG
DE000A0KFRJ1

Annual General Meeting of CytoTools AG votes for dismissal of all Supervisory Board members Darmstadt, 30 September 2021 - CytoTools AG (ISIN DE000A0KFRJ1), a biotechnology holding company specializing in pharmaceutical and medical products, today held its Annual General Meeting in virtual form. Of the company's share capital of EUR 4,028,000.00,  [ … ]
Technical analysis
To the publication
Thu, 30.09.2021       CytoTools AG
DE000A0KFRJ1

Supervisory Board of CytoTools AG announces the retirement of the two members of the Management Board according to schedule - Management Board members Dr. Freyberg and Dr. Kaiser not available for contract extensions after being voted out of office by the Supervisory Board - Management Board contracts expire by rotation today Darmstadt, 30 Septem [ … ]
Technical analysis
To the publication
Wed, 29.09.2021       CytoTools AG
DE000A0KFRJ1

CytoTools AG considers complete change of Management Board and Supervisory Board possible as a result of the Annual General Meeting on 30.09.2021 Darmstadt, 29 September 2021 - CytoTools AG has invited to the ordinary (virtual) shareholders' meeting for September 30, 2021. Under agenda item 8, the Annual General Meeting is to vote on the proposal  [ … ]
Technical analysis
To the publication
Wed, 29.09.2021       CytoTools AG
DE000A0KFRJ1

CytoTools Reports Progress of DermaPro(R) Phase III Study in Europe and Provides Operational Status Update - Good progress in patient recruitment for Phase III study despite unforeseen delays due to COVID-19 - Sales of Woxheal(R) gaining significant momentum since September - Further development steps of DPOCL inhalation therapy suspended as a prec [ … ]
Technical analysis
To the publication
Tue, 29.06.2021       CytoTools AG
DE000A0KFRJ1

CytoTools cures resolution of 2020 Annual General Meeting with proposed capital increase - Resolution on added items to the 2020 agenda proved to be unfeasible from a technical point of view - Proposal to the 2021 Annual General Meeting is essentially the same as the resolution adopted in 2020 Darmstadt, 29 June 2021 - CytoTools AG (ISIN DE000A0KF [ … ]
Technical analysis
To the publication
Mon, 21.06.2021       CytoTools AG
DE000A0KFRJ1

CytoTools Q1 Trading Update: Treatment numbers in India slightly above previous quarter despite significant pandemic impact - Over 10,000 use cases in Q1 despite tough lockdown in India - Expansion into Africa following provisional approval of Woxheal in Kenya Darmstadt, 21 June 2021 - CytoTools AG (ISIN DE000A0KFRJ1), a biotechnology holding comp [ … ]
Technical analysis
To the publication
Mon, 26.04.2021       CytoTools AG
DE000A0KFRJ1

CytoTools signs collaboration agreement to develop inhalation therapy for viral infections such as COVID-19 and influenza - Cooperation with medical technology specialists for inhalative applications - Regulatory approval with early out-licensing targeted - Completion of further development steps planned by end of third quarter Darmstadt, 26 April [ … ]
Technical analysis
To the publication
Mon, 21.12.2020       CytoTools AG
DE000A0KFRJ1

CytoTools receives confirmation of efficacy of DPCOL also against influenza viruses - Virus-killing effect of DPOCL also confirmed with regard to influenza viruses - Novel therapeutic approach thus also of high commercial interest beyond Corona pandemic - Final results report on Sars-CoV-2 virus confirms efficacy of more than 95 percent Darmstadt, [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 01.07.2024, Calendar Week 27, 183rd day of the year, 183 days remaining until EoY.